Although FGFR2 mutations are considered rare in ovarian cancer, the Ser252Trp mutation seen in endometrial cancer has also been detected in the ovary cancer 38, suggesting a loss of ligand specificity for FGF signaling in at least some ovarian cancers. The gene discussed is FGFR2; the disease is ovarian cancer.